Neurobiogen
a bio-pharmaceutical company committed to the discovery and development of new drugs to treat diseases for which there is significant unmet medical need.
Neurobiogen has developed the NB-3108, a new class of neuroprotective agent for the treatment of Alz
neurobiogen, biomed, NB-3108, MICROS Infusion, neuroprotection, Alzheimer's diseases.Parkinson's diseases, dementia, neurological disorder,
Is this your site? Certify your site and update informations
